BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

784 related articles for article (PubMed ID: 19207376)

  • 21. Risk of sensitization to preservatives estimated on the basis of patch test data and exposure, according to a sample of 3541 leave-on products.
    Schnuch A; Mildau G; Kratz EM; Uter W
    Contact Dermatitis; 2011 Sep; 65(3):167-74. PubMed ID: 21692811
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preservatives in registered chemical products.
    Flyvholm MA
    Contact Dermatitis; 2005 Jul; 53(1):27-32. PubMed ID: 15982228
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Formaldehyde in cosmetics in patch tested dermatitis patients with and without contact allergy to formaldehyde.
    Hauksson I; Pontén A; Isaksson M; Hamada H; Engfeldt M; Bruze M
    Contact Dermatitis; 2016 Mar; 74(3):145-51. PubMed ID: 26696132
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Difficulties in avoiding exposure to allergens in cosmetics.
    Noiesen E; Munk MD; Larsen K; Johansen JD; Agner T
    Contact Dermatitis; 2007 Aug; 57(2):105-9. PubMed ID: 17627650
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Iodopropynyl butylcarbamate.
    Badreshia S; Marks JG
    Am J Contact Dermat; 2002 Jun; 13(2):77-9. PubMed ID: 12022126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Formaldehyde and formaldehyde releasers: how much avoidance of cross-reacting agents is required?
    Herbert C; Rietschel RL
    Contact Dermatitis; 2004 Jun; 50(6):371-3. PubMed ID: 15274729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Formaldehyde exposure and patterns of concomitant contact allergy to formaldehyde and formaldehyde-releasers.
    Lundov MD; Johansen JD; Carlsen BC; Engkilde K; Menné T; Thyssen JP
    Contact Dermatitis; 2010 Jul; 63(1):31-6. PubMed ID: 20597931
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Allergic contact dermatitis to cosmetics].
    Laguna C; de la Cuadra J; Martín-González B; Zaragoza V; Martínez-Casimiro L; Alegre V
    Actas Dermosifiliogr; 2009; 100(1):53-60. PubMed ID: 19268112
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Failures in risk assessment and risk management for cosmetic preservatives in Europe and the impact on public health.
    Schwensen JF; White IR; Thyssen JP; Menné T; Johansen JD
    Contact Dermatitis; 2015 Sep; 73(3):133-41. PubMed ID: 26184096
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cosmetic preservative labeling in Philippine products in accordance with Philippine regulations.
    Lim SO; Isaksson M; Persson L; Dahlin J; Bruze M
    Contact Dermatitis; 2022 Jun; 86(6):524-530. PubMed ID: 35150015
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Preservatives Across All Product Types in the Contact Allergen Management Program.
    Beene KM; Scheman A; Severson D; Reeder MJ
    Dermatitis; 2017; 28(1):81-87. PubMed ID: 28098722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Allergic contact dermatitis in preservatives: current standing and future options.
    Deza G; Giménez-Arnau AM
    Curr Opin Allergy Clin Immunol; 2017 Aug; 17(4):263-268. PubMed ID: 28548971
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylisothiazolinone.
    Castanedo-Tardana MP; Zug KA
    Dermatitis; 2013; 24(1):2-6. PubMed ID: 23340392
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Contact dermatitis from methylisothiazolinone in a paint factory.
    Thyssen JP; Sederberg-Olsen N; Thomsen JF; Menné T
    Contact Dermatitis; 2006 Jun; 54(6):322-4. PubMed ID: 16787453
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact sensitization to methylisothiazolinone in Finland--a multicentre study.
    Ackermann L; Aalto-Korte K; Alanko K; Hasan T; Jolanki R; Lammintausta K; Lauerma A; Laukkanen A; Liippo J; Riekki R; Vuorela AM; Rantanen T
    Contact Dermatitis; 2011 Jan; 64(1):49-53. PubMed ID: 21166817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Methyldibromoglutaronitrile: skin sensitization and quantitative risk assessment.
    Basketter DA
    Cutan Ocul Toxicol; 2010 Mar; 29(1):4-9. PubMed ID: 19883218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preservatives in cosmetics: reactivity of allergenic formaldehyde-releasers towards amino acids through breakdown products other than formaldehyde.
    Kireche M; Gimenez-Arnau E; Lepoittevin JP
    Contact Dermatitis; 2010 Oct; 63(4):192-202. PubMed ID: 20731691
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low-level efficacy of cosmetic preservatives.
    Lundov MD; Johansen JD; Zachariae C; Moesby L
    Int J Cosmet Sci; 2011 Apr; 33(2):190-6. PubMed ID: 21272037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preservatives in cosmetics in the Israeli market conform well to the EU legislation.
    Horev L; Isaksson M; Engfeldt M; Persson L; Ingber A; Bruze M
    J Eur Acad Dermatol Venereol; 2015 Apr; 29(4):761-6. PubMed ID: 25175339
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Temporal trends of preservative allergy in Denmark (1985-2008).
    Thyssen JP; Engkilde K; Lundov MD; Carlsen BC; Menné T; Johansen JD
    Contact Dermatitis; 2010 Feb; 62(2):102-8. PubMed ID: 20136893
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 40.